Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia
Published inBlood, vol. 114, no. 7, p. 1383-1386
Publication date2009
Abstract
Keywords
- 6-Mercaptopurine/therapeutic use
- Adolescent
- Alleles
- Amino Acid Substitution
- Antimetabolites, Antineoplastic/therapeutic use
- Child
- Child, Preschool
- Disease-Free Survival
- Female
- Gene Frequency
- Genotype
- Humans
- Male
- Methotrexate/therapeutic use
- Multidrug Resistance-Associated Proteins/genetics
- Mutation, Missense
- Pilot Projects
- Polymorphism, Single Nucleotide
- Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/genetics/mortality
- Promoter Regions, Genetic/genetics
- Retrospective Studies
- Survival Rate
Research group
Citation (ISO format)
ANSARI DJABERI, Marc Georges et al. Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia. In: Blood, 2009, vol. 114, n° 7, p. 1383–1386. doi: 10.1182/blood-2008-11-191098
Main files (1)
Article (Published version)
Identifiers
- PID : unige:43455
- DOI : 10.1182/blood-2008-11-191098
- PMID : 19515727
ISSN of the journal0006-4971